Affiliation:
1. School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173212, India
2. School of Pharmaceutical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, 173212,
India
3. Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo NSW2007, Australia
Abstract
Abstract:
The vagina is an essential part of the female reproductive system and offers many potential
benefits over conventional drug delivery, including a large surface area for drug absorption, relatively
low enzymatic activity, avoiding first-pass effects, and ease of administration. The vaginal
mucosal cavity is an effective route for administering therapeutic agents that are intended both for
local and systemic administration. The present review provides a comprehensive overview of recent
trends and developments in vaginal drug delivery. Marketed formulations and products under clinical
study are also reviewed. Various novel vaginal delivery systems have been studied in recent
years as effective tools for delivering a range of therapeutic agents to the vagina. These systems offer
numerous benefits, including sustained delivery, improved bioavailability, effective permeation,
and higher efficacy. The recent focus of the scientific community is on the development of safe and
efficient drug delivery systems, such as nanoparticles, microparticles, vesicular systems, vaginal
rings, microneedles, etc., for vaginal application. Various factors, such as the physicochemical properties
of the drugs, the volume and composition of the vaginal fluid, the pH of the vaginal fluid, the
thickness of the vaginal epithelium, and the influence of sexual intercourse may influence the release
of drugs from the delivery system and subsequent absorption from the vaginal route. To date,
only a limited number of in vivo studies on novel vaginal DDS have been reported. Additionally,
drug release kinetics under varying vaginal environments is also not well understood. More research
is needed to ensure the suitability, biocompatibility, and therapeutic effectiveness of novel DDS for
vaginal delivery. Although numerous strategies and interventions have been developed, clinical
translation of these systems remains a challenge. The toxicity of the carrier system is also an important
consideration for future clinical applications.
Publisher
Bentham Science Publishers Ltd.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献